Nothing said here yet.
to join the conversation.
| Malik Muhammad ShahbazSenior VP, BAS | Buy | 478 | $25.0K | Fri, Oct 16 |
| BAILLY R JEFFREYDirector | Buy | 10,000 | $500.0K | Wed, Oct 7 |
| Martin Celine ChristineDirector | Buy | 464 | $23.0K | Wed, Sep 30 |
| Lauber Charles TDirector | Buy | 2,005 | $100.0K | Tue, Sep 29 |
| Happe Michael JDirector | Buy | 2,000 | $99.3K | Tue, Sep 29 |
| Zaheer SrilataDirector | Buy | 40 | $2.0K | Tue, Sep 29 |
| FLORNESS DANIEL LDirector | Buy | 2,030 | $100.2K | Mon, Sep 28 |
| HANDLEY THOMAS WDirector | Buy | 2,000 | $98.8K | Mon, Sep 28 |
| Zaheer SrilataDirector | Buy | 2,000 | $98.1K | Mon, Sep 28 |
| Rasmussen Trangsrud Teresa JDirector | Buy | 1,542 | $75.5K | Mon, Sep 28 |
| Rasmussen Trangsrud Teresa JDirector | Buy | 500 | $24.5K | Mon, Sep 28 |
H.B. Fuller (FUL) just tapped the debt markets by issuing US$850m of 7.625% senior unsecured notes due 2034, a move closely linked to funding its planned Advanced Medical Solutions Group acquisition.
H.B. Fuller has seen its share price slide in recent years, and with the stock recently closing at US$49.61, the key issue for you is whether that current level makes sense when set against the cash the business can generate over time.
H. B. Fuller (FUL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
FUL prices $850M in senior notes to finance its AMS acquisition and refinance debt, with a 7.625% coupon and a key redemption condition tied to the deal.
Insiders at H.B. Fuller, FocalTherics, and Cardinal Infrastructure Group are buying shares, signaling potential bottoms backed by analyst price targets, institutional ownership, and growth catalysts.
H.B. Fuller (FUL) said Thursday it has priced a private offering of $850 million of its 7.625% senio